Welcome : Guest

DNA PROBES-BASED DIAGNOSTICS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 46 companies including many key and niche players such as -

Abbott Molecular
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMérieux
F. Hoffmann-La Roche Ltd.
GE Healthcare Life Sciences

Click here to request a full list of companies covered in the report...

Code: MCP-3405
Price: $4500
Companies: 46
Pages: 236
Date: April 2018
Market Data Tables: 99
  Status: * New Report



TABLE OF CONTENTS


  DNA PROBES-BASED DIAGNOSTICS (Complete Report) Pages : 236   | $4500

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   What are DNA-Probes?.....II-1
DNA-based Diagnostics – A Prelude.....II-1
1$100
   DNA Tests: Finding Use in Numerous Applications.....II-2
DNA Probes: Robust Growth Ahead.....II-2
1$100
   Developed Markets: Traditional Revenue Contributors.....II-3
The United States: Unraveling the Country’s Edge in DNA-based Diagnostics.....II-3
1$100
   Infectious Diseases Tests Dominate the DNA-based Diagnostics Market.....II-4
Developing Countries Excel in Growth Prospects.....II-4
1$100
   Decoding the Genetic Puzzle.....II-51$100
   Advantages of DNA-Probe Tests.....II-6
Growth Drivers in a Nutshell.....II-6
Growth Inhibitors in a Nutshell.....II-6
Genetic Profiling of Pathogens: A Road Less Traveled.....II-6
1$100
   Roche’s Entry into the Hall of Molecular Fame.....II-7
DNA Technology: An Evolutionary Scan.....II-7
1$100
   Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005.....II-81$100
   Market Opportunities.....II-91$100
   World’s Aging Population Drives the Popularity of DNA-Probe Tests.....II-10
Global Aging Population Statistics – Opportunity Indicators.....II-10
Table 1: Global Population of 65+ Individuals in ‘000s by Region for the Years 2015, 2020 & 2025 (includes corresponding Graph/Chart).....II-10
1$350
   Table 2: Global Population Statistics for the 65+ Age Group in Select Countries (2017) (includes corresponding Graph/Chart).....II-111$350
   Table 3: Life Expectancy at Birth (in Years) by Region for 2010-2015, 2020-2025 & 2045-2050 (includes corresponding Graph/Chart).....II-12
Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based
  Diagnostics.....II-12
1$350
   Table 4: Worldwide Cancer Prevalence (2017): Percentage Prevalence of Diagnosed Cancer Conditions in Adult Population in Select Countries (includes corresponding Graph/Chart).....II-131$350
   Table 5: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart).....II-141$350
   Table 6: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart).....II-151$350
   Table 7: Worldwide Diabetes Prevalence (2017 & 2045): Percentage Prevalence of Diabetes in Adult Population (20-79 Years) by Geographic Region (includes corresponding Graph/Chart).....II-16

Table 8: Leading Countries with Diabetes Population (20-79 Years) in Million for the Years 2017 and 2045 (includes corresponding Graph/Chart).....II-16
1$350
   AIDS: A Global Epidemic.....II-17
Facts & Figures.....II-17
1$100
   Table 9: HIV Infection Statistics Worldwide by Geographic Region: As of 2016 (includes corresponding Graph/Chart).....II-18

Table 10: HIV Infection Statistics Worldwide for Adults, Women and Children: As of 2016 (includes corresponding Graph/Chart).....II-18
1$350
   Table 11: Worldwide AIDS Related Deaths by Geographic Region: 2016 (includes corresponding Graph/Chart).....II-19
Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth.....II-19
1$350
   Table 12: Healthcare Spending as a Percentage of GDP in Select Countries (2016) (includes corresponding Graph/Chart).....II-20
Reimbursements: “Under the Umbrella”.....II-20
1$350
   Evolution of New & Virulent Infectious Agents.....II-21
Challenges in Widespread Deployment of DNA-based Diagnostics.....II-21
Improvements in Assay Capabilities.....II-21
Information Handling & Processing: The Soft Side of Diagnostics.....II-21
1$100
   Integration: The Ultimate Challenge.....II-22
DNA Probe Technology Gains Prominence in Diagnosing Vaginitis.....II-22
Gene Banks – A Ray of Hope for the Future.....II-22
1$100
   Diagnostic Gene Detection Products.....II-23
Molecular Diagnostics: A Powerful Disease Detection Tool.....II-23
1$100
   DNA Probes-Based Products.....II-24
Direct Detection of Target Sequence.....II-24
Nucleic Acid Amplification.....II-24
1$100
   Gene Detection Using DNA Chips.....II-25
Gene Detection by DNA Sequencing.....II-25
The Dynamics of Key Enabling Technologies.....II-25
Polymerase Chain Reaction (PCR).....II-25
In Situ Hybridization.....II-25
1$100
   Chemiluminescence.....II-26
Gen-Probe Tigris.....II-26
DNA Chips.....II-26
Molecular Diagnostics – A Primer.....II-26
1$100
   Implications for Clinical Diagnostics.....II-27
Need of the Hour.....II-27
Impact of the Human Genome Project.....II-27
1$100
   “Tailored Patient Management”: An Epitomized Future of Molecular Diagnostics.....II-28
Outlook.....II-28
2$200
   Background.....II-30
Gene Probe Technology.....II-30
What is DNA?.....II-30
DNA Probes.....II-30
1$100
   Miniaturization: A Revolutionary Method in DNA Analysis.....II-31
Gene Chip Technology.....II-31
DNA Chips.....II-31
Chromosome Painting Probes.....II-31
Diagnostic Applications Based on DNA Probes: An Overview.....II-31
Infectious Diseases.....II-31
2$200
   Respiratory Tract Infections.....II-33
Diagnosis of Mycoplasma.....II-33
DNA Probes to Detect Legionella Pneumophila.....II-33
Detecting Tuberculosis through Rapid Diagnostic Tests.....II-33
How the Technique Works.....II-33
1$100
   Limitations.....II-34
Sexually Transmitted Diseases (STDs).....II-34
HIV.....II-34
HTLV-1 Testing.....II-34
Hepatitis Testing.....II-34
Chlamydia DNA Probes.....II-34
Detection of Intestinal Parasites.....II-34
Entamoeba Histolytica.....II-34
1$100
   Salmonella.....II-35
Malaria Testing.....II-35
Identity/Forensics.....II-35
DNA Profiling: A Key Forensic Tool.....II-35
DNA-Based Forensic Diagnostics.....II-35
1$100
   Tracing Human Origins.....II-36
Genetic Predisposition.....II-36
1$100
   Molecular HLA Testing.....II-37
Human Leukocyte Antigen (HLA) Typing.....II-37
Cancer Testing.....II-37
Cancer: A Deadly Disease Afflicting Millions.....II-37
Slow Detoxifiers: Potential Cancer Candidates.....II-37
1$100
   Improving Cancer Surgery through Diagnostic Tests.....II-38
Types of Cancer.....II-38
Chronic Lymphocytic Leukemia (CLL).....II-38
Breast Cancer.....II-38
PCR Screening Technology for Breast Cancer.....II-38
1$100
   Eye Cancers.....II-39
DNA Probes to Detect Retinoblastoma.....II-39
Others.....II-39
The Ames Test.....II-39
Genetic Testing.....II-39
1$100
   Other Diagnostic Applications.....II-40
Cystic Fibrosis.....II-40
Duchenne’s Muscular Dystrophy.....II-40
Huntington’s Disease.....II-40
Diabetes.....II-40
1$100
   Detection of Multidrug Resistance.....II-41
Bacterial Resistance to Antibiotics.....II-41
1$100
   Thermo Fisher Scientific Acquires Affymetrix.....II-42
Illumina Partners with Memorial Sloan Kettering.....II-42
Cancer Genetics to Acquire BioServe Biotechnologies.....II-42
1$100
   Abbott Molecular (USA).....II-43
Beckman Coulter, Inc. (USA).....II-43
1$100
   Becton, Dickinson and Company (USA).....II-44
bioMérieux (France).....II-44
1$100
   F. Hoffmann-La Roche Ltd. (Switzerland).....II-45
GE Healthcare Life Sciences (UK).....II-45
1$100
   Luminex Corporation (USA).....II-46
QIAGEN N.V. (Netherlands).....II-46
1$100
   Siemens Healthineers (Germany).....II-47
Thermo Fisher Scientific, Inc. (USA).....II-47
1$100
   Table 13: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-481$350
   Table 14: World Historic Review for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-491$350
   Table 15: World 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....II-501$350
   Table 16: World Recent Past, Current & Future Analysis for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-511$350
   Table 17: World Historic Review for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-521$350
   Table 18: World 14-Year Perspective for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....II-531$350
   Table 19: World Recent Past, Current & Future Analysis for DNA Probes-based Cancer Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-541$350
   Table 20: World Historic Review for DNA Probes-based Cancer Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-551$350
   Table 21: World 14-Year Perspective for DNA Probes-based Cancer Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....II-561$350
   Table 22: World Recent Past, Current & Future Analysis for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-571$350
   Table 23: World Historic Review for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-581$350
   Table 24: World 14-Year Perspective for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....II-591$350
   Table 25: World Recent Past, Current & Future Analysis for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-601$350
   Table 26: World Historic Review for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-611$350
   Table 27: World 14-Year Perspective for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....II-621$350
   Table 28: World Recent Past, Current & Future Analysis for DNA Probes-based Other Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-631$350
   Table 29: World Historic Review for DNA Probes-based Other Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-641$350
   Table 30: World 14-Year Perspective for DNA Probes-based Other Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....II-651$350
   A. Market Analysis.....III-1
United States: The Largest Market for DNA-Probes Diagnostics.....III-1
1$75
   Key Challenges Facing the Market.....III-2
Rise of DNA-Based Home Testing Kits Market.....III-2
Ageing Demographics: A Major Driving Factor.....III-2
1$75
   Table 31: US Elderly Population by Age Group for Years 1990, 2000, 2010 and 2015 (includes corresponding Graph/Chart).....III-3
Diabetes Pandemic in the US: An Opportunity for DNA Probes-based Diagnostics.....III-3
1$200
   Table 32: Diabetes Statistics in the US (2017 & 2045) (includes corresponding Graph/Chart).....III-4

Table 33: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart).....III-4
Growing Cancer Incidence – An Opportunity Indicator for DNA Probes-Based
  Diagnostics.....III-4
1$200
   Table 34: New Cancer Cases in the US by Gender and Affected Site: 2017 (includes corresponding Graph/Chart).....III-51$200
   Table 35: Incidence of Four Major Cancers by Gender & Age Group in the US (2017): New Cancer Cases for Male & Female for the Age Groups Under 45 Years; 45 Years and Above; Under 65 Years; 65 Years and Above (includes corresponding Graph/Chart).....III-61$200
   Table 36: The US Breast Cancer Incidence in Women by State (2017): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart).....III-7
Strategic Corporate Developments.....III-7
1$200
   Focus on Select Key Players.....III-83$225
   B. Market Analytics.....III-11
Table 37: The US Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-11
1$200
   Table 38: The US Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-121$200
   Table 39: The US 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-131$200
   A. Market Analysis.....III-14
A. Market Analysis.....III-14
1$75
   Cancer Incidence in Canada: Opportunity Indicator.....III-15
Table 40: New Cancer Cases in Canada (2017): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart).....III-15
1$200
   Table 41: New Cancer Cases in Canada by Province: 2017 (includes corresponding Graph/Chart).....III-161$200
   Table 42: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart).....III-171$200
   Table 43: Cancer Related Deaths in Canada (2017): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart).....III-181$200
   Diabetes Overview.....III-19
Table 44: Diabetes Statistics in Canada (2017 & 2045) (includes corresponding Graph/Chart).....III-19
1$200
   Table 45: Percentage Share Breakdown of Diabetic Population by Gender in Canada: 2016 (includes corresponding Graph/Chart).....III-20

Table 46: Percentage Share Breakdown of Diabetic Population by Age Group in Canada: 2016 (includes corresponding Graph/Chart).....III-20
1$200
   B. Market Analytics.....III-21
Table 47: Canadian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-21
1$200
   Table 48: Canadian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-221$200
   Table 49: Canadian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Graying Population Spurs Growth.....III-24
Table 50: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-24
1$200
   Diabetes Statistics.....III-25
Table 51: Diabetes Statistics in Japan (2017 & 2045) (includes corresponding Graph/Chart).....III-25
1$200
   B. Market Analytics.....III-26
Table 52: Japanese Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-26
1$200
   Table 53: Japanese Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-271$200
   Table 54: Japanese 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Ageing Population Drives Demand.....III-29
1$75
   Table 55: European Country-wise Statistics of 65+ Population as % of Total Population: 2016 (includes corresponding Graph/Chart).....III-301$200
   Cancer Incidence in Europe: An Opportunity Indicator for DNA Probes-Based
  Diagnostics.....III-31
Table 56: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart).....III-31
1$200
   A Glance at Key Diabetes Statistics in Europe.....III-32
Table 57: Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart).....III-32
1$200
   Table 58: Diabetes Statistics in Europe (2017) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-331$200
   B. Market Analytics.....III-34
Table 59: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-34
1$200
   Table 60: European Historic Review for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-351$200
   Table 61: European 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-361$200
   Table 62: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-371$200
   Table 63: European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   Table 64: European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
bioMérieux – A Major French Player.....III-40
1$75
   B. Market Analytics.....III-41
Table 65: French Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-41
1$200
   Table 66: French Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-421$200
   Table 67: French 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-431$200
   A. Market Analysis.....III-44
Siemens Healthineers – A Key German Player.....III-44
1$75
   B. Market Analytics.....III-45
Table 68: German Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-45
1$200
   Table 69: German Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-461$200
   Table 70: German 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-471$200
   Market Analysis.....III-48
Table 71: Italian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-48
1$200
   Table 72: Italian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-491$200
   Table 73: Italian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
GE Healthcare Life Sciences – A Leading UK Player.....III-51
1$75
   B. Market Analytics.....III-52
Table 74: The UK Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-52
1$200
   Table 75: The UK Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-531$200
   Table 76: The UK 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 77: Spanish Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-55
1$200
   Table 78: Spanish Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-561$200
   Table 79: Spanish 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-571$200
   Market Analysis.....III-58
Table 80: Russian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-58
1$200
   Table 81: Russian Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-591$200
   Table 82: Russian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-601$200
   A. Market Analysis.....III-61
Focus on Select Key Players.....III-61
2$150
   B. Market Analytics.....III-63
Table 83: Rest of European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-63
1$200
   Table 84: Rest of European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-641$200
   Table 85: Rest of European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-651$200
   A. Market Analysis.....III-66
Diabetes Statistics – An Overview.....III-66
1$75
   Table 86: Diabetes and Population Statistics in Western Pacific (2017 & 2045) (includes corresponding Graph/Chart).....III-671$200
   Table 87: Diabetes Statistics in Western Pacific (2017) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-681$200
   Table 88: Diabetes and Population Statistics in South East Asia (2017 & 2045) (includes corresponding Graph/Chart).....III-691$200
   Table 89: Diabetes Statistics in South East Asia (2017) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-70
Strategic Corporate Development.....III-70
1$200
   B. Market Analytics.....III-71
Table 90: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-71
1$200
   Table 91: Asia-Pacific Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-721$200
   Table 92: Asia-Pacific 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-731$200
   A. Market Analysis.....III-74
Diabetes in Latin America – A Glance at Key Statistics.....III-74
1$75
   Table 93: Diabetes and Population Statistics in Central and South America (2017 & 2045) (includes corresponding Graph/Chart).....III-751$200
   Table 94: Diabetes Statistics in South & Central America (2017) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-761$200
   Diabetes in Middle East & North Africa, and Africa – Key Statistics.....III-77
Table 95: Diabetes and Population Statistics in Middle East & North Africa (2017 & 2045) (includes corresponding Graph/Chart).....III-77

Table 96: Diabetes and Population Statistics in Africa (2017 & 2045) (includes corresponding Graph/Chart).....III-77
1$200
   B. Market Analytics.....III-78
Table 97: Rest of World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-78
1$200
   Table 98: Rest of World Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-791$200
   Table 99: Rest of World 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart).....III-801$200
  
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 57)

Region/Country Players

The United States 37 Canada 2 Japan 1 Europe 13 France 1 Germany 3 The United Kingdom 2 Italy 1 Spain 1 Rest of Europe 5 Asia-Pacific (Excluding Japan) 4
Click here to request a full table of contents and more details on this project.